| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT00910273 Details | 2016-01-13 Interventional | 4 | 34 | Etanercept Spondylarthriti… Spondylitis Spondylitis, An… Ankylosing Spon… | - Due to early termination and few participants attending visits after Week 12, statistical analysis limited to Week 12. | |||
| NCT00673361 Details | 2016-01-13 Interventional | 2 | 9 | Sorafenib Temozolomide Melanoma | - - | |||
| NCT01093092 Details | 2016-01-12 Interventional | 1 | 14 | Calcitriol Dihydroxycholec… Gemcitabine Adult Solid Neo… | Study transferring to INOVA Health - | |||
| NCT00718523 Details | 2016-01-12 Interventional | 2 | 170 | Antibodies, Mon… Carcinoma, Ovar… Ovarian Neoplas… | The steering committee of the TRIO014 study has taken the decision to stop the TRIO014 trial. - | |||
| NCT02229240 Details | 2016-01-11 Interventional | 3 | 0 | Glucagon-Like P… rGLP-1 protein Diabetes Mellit… Diabetes Mellit… | Study was cancelled prior to enrolling any patients - | |||
| NCT00387777 2006-003177-27 Details | 2016-01-11 Interventional | 1 | - | Analgesics Buprenorphine Healthy | - - | |||
| NCT00364429 Details | 2016-01-11 Interventional | 1 | 55 | Lorazepam Risperidone Schizophrenia | terminated - | |||
| NCT02144246 Details | 2016-01-08 Interventional | 1 | 5 | Estradiol Estradiol 17 be… Estradiol 3-ben… Ethinyl Estradi… Moxifloxacin Norgestimate Norgestimate, e… Norgestrel Polyestradiol p… Cystic Fibrosis Fibrosis Cystic Fibrosis… | - - | |||
| NCT01927055 Details | 2016-01-08 Interventional | 3 | 61 | Droxidopa Mannitol Hypotension Hypotension, Or… Multiple System… Parkinson Disea… Pure Autonomic … Shy-Drager Synd… Dopamine Beta H… Multiple System… Parkinson's Dis… Symptomatic Neu… | Due to potential competition with a post-marketing study requested by FDA The study was prematurely terminated; the limited sample size precludes meaningful conclusions on the efficacy or safety of droxidopa in this study. | |||
| NCT01546688 2006-002516-10 Details | 2016-01-08 Interventional | 4 | 41 | Zonisamide Seizures Epilepsy | - - | |||
| NCT00984217 Details | 2016-01-08 Interventional | 2 | 0 | Panitumumab Adenoma Adenoma, Pleomo… Neoplasms Salivary Gland … Syringoma Mixed Salivary … Salivary Gland … Syringoma, Chon… | Decided not to pursue at UPCI - | |||
| NCT02409433 Details | 2016-01-07 Interventional | 4 | 3 | Lacosamide Phenytoin Seizures | due to slow recruitment and budgetary restraints study was prematurely terminated - | |||
| NCT00022490 Details | 2016-01-07 Interventional | 2 | 24 | Cytarabine Imatinib Mesyla… Leukemia Leukemia, Myelo… Leukemia, Myelo… | - Study was terminated, therefore the 12 month response data was not analyzed. | |||
| NCT02532192 Details | 2016-01-06 Interventional | 1 | 0 | Belinostat Ciprofloxacin Cisplatin Cytarabine Dexamethasone Fluconazole Rituximab Lymphoma Lymphoma, B-Cel… Lymphoma, Large… | Withdrawal of study support. - | |||
| NCT02324491 Details | 2016-01-06 Interventional | 2 | 152 | CKD732 Diabetes Mellit… Diabetes Mellit… Obesity Type 2 Diabetes | Sponsor decision to analyze available safety and efficacy data - | |||
| NCT01510847 Details | 2016-01-06 Interventional | 4 | 19 | Testosterone un… Assess the Effe… | Unable to reach the target recruitment within timeline - | |||
| NCT01420666 Details | 2016-01-06 Interventional | 3 | 0 | Acetaminophen Ibuprofen Osteoarthritis | The study was withdrawn for administrative reason - | |||
| NCT00492531 Details | 2016-01-06 Interventional | 2 | 74 | Phosphodiestera… Sildenafil Citr… Anemia, Sickle … Hypertension Hypertension, P… Pulmonary Hyper… Sickle Cell Dis… | Subjects on drug were more likely to have severe pain crises requiring hospitalization. As a result of early termination due to safety findings, the study was underpowered to assess the effects of sildenafil therapy on the predetermined efficacy endpoints. | |||
| NCT00421317 Details | 2016-01-06 Interventional | 2 | 13 | Imatinib Mesyla… Melanoma | Study stopped at the end of the first step - | |||
| NCT01067274 Details | 2015-12-30 Interventional | 3 | 0 | Azacitidine Cytarabine Tretinoin Leukemia Leukemia, Myelo… Leukemia, Myelo… Acute Myeloid L… | Study abandoned - |